Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data VERDE BIO HOLDINGS, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
0
0
0
0.05
0.04
0
Cost of revenue
0
0.02
0.02
0
Gross profit
0
0.03
0.02
0
0
-0
General and administrative
-0
0.06
0.02
0.08
0.09
0.01
Operating expenses
0.13
0.23
0.2
0.48
0.47
0.04
0.26
3.01
3.87
2.57
Operating income
-0.13
-0.23
-0.2
-0.46
-0.45
-0.04
-0.26
-2.97
-3.15
-1.64
Interest expense
0
0.13
0.02
0.18
0.3
0.35
0.23
0.37
0
0.07
Other non-operating income
-0.27
-0.56
0.07
-1.67
-1.04
-0.5
-1.32
-0.35
-0.27
-0.13
Pre-tax income
-0.4
-0.8
-0.13
-2.12
-1.5
-0.54
-1.58
-3.32
-3.42
-1.77
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-0.4
-0.8
-0.13
-2.12
-1.5
-0.54
-1.58
0
-3.44
-1.86
EBITDA
-0.13
-0.26
-2.97
-3.12
-1.58
EPS, basic
-28,754.00
-5,247.00
-52.47
-157.41
-5.30
-0.01
-1.03
-0.03
0.00
EPS, diluted
-28,754.00
-5,247.00
-52.47
-157.41
-5.30
-0.53
-1.03
-0.03
0.00
Shares, basic (weighted)
0
0
0
0.01
0.28
1.02
1.53
94.8
1,139
Shares, diluted (weighted)
0
0
0
0.01
0.28
1.02
1.53
94.8
1,139
Balance sheet
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Cash and equivalents
0.01
0
0
0.02
0.01
0.02
0
2.09
0.14
0.03
Receivables
0
0
0
0.01
0
0.07
Other current assets
0
0
0.04
0.01
0
0
0.03
0.03
0
Total current assets
0.01
0
0
2.21
0.3
0.1
Property, plant and equipment
0
2.78
2.72
Lease right-of-use assets
0
0.12
0.07
0.02
Total assets
0.01
0
0
0.06
0.02
0.02
0
3.22
5.09
4.16
Accounts payable
0.08
0.12
0.2
0.27
0.42
0.48
0.33
0.21
0.17
0.29
Accrued liabilities
0.04
Total current liabilities
0.48
3.14
0.48
1.45
1.84
Lease liabilities
0
0.08
0.02
0
Total liabilities
0.27
0.59
0.48
1.61
1.55
2.03
3.14
0.56
1.47
1.84
Paid-in capital
0.6
1.08
1.28
2.38
3.82
3.94
4.38
12.1
16.7
16.7
Retained earnings
-0.87
-1.67
-1.79
-3.91
-5.41
-5.95
-7.52
-10.8
-14.3
-16
Shareholders' equity
-0.27
-0.59
-0.48
-1.55
-1.52
-2.01
-3.13
2.66
3.59
2.21
Total equity
-0.27
-0.59
-0.48
-1.55
-1.52
-2.01
-3.13
2.66
3.59
2.21
Total liabilities and equity
0.01
0
0
0.06
0.02
0.02
0
3.22
5.09
4.16
Shares outstanding
0
0
0.01
0.05
1.19
1.07
1.83
683
1,179
1,543
Cash flow statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Net income
-0.4
-0.8
-0.13
-2.12
-1.5
-0.54
-1.58
-3.32
-3.42
-1.77
Depreciation and amortization
0
0
0
0.03
0.06
Change in receivables
-0
0
-0
-0.01
-0
0.01
0
-0.09
-0.04
0.05
Change in payables
-0.02
0.04
0.07
0.1
0.23
0.06
0.14
0.21
-0
0.12
Cash from operations
-0.05
-0.06
-0.01
-0.27
-0.23
-0.02
-0.18
-0.69
-1.15
-0.87
Capital expenditures
-2.87
-0.01
Cash from investing
0
-2.5
-5.68
0.15
Debt repaid
0
-0.02
Stock issued
0
5.36
3.92
Cash from financing
0.06
0.06
0.01
0.28
0.22
0.03
0.16
5.27
4.88
0.61
Net change in cash
-1.95
-0.12
Free cash flow
-4.02
-0.88
Interest paid
0
0
0
0
0
0
0
0.03
Income taxes paid
0
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to January 31, 2024; growth uses fiscal years. Valuation uses the share price of $1.28 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-2,238.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-141.5%
Net income / average total assets.
Return on invested capital (ROIC)
-1,061.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-38.4%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-18.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
1,266.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
180.9%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
21,733x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
21,733x
Market cap / tangible book value, when positive.
Earnings yield
-0.1%
Net income / market cap (the inverse of P/E).
Was VERDE BIO HOLDINGS, INC. profitable in fiscal 2023?
No. It reported a net loss of $1.9M.
How much free cash flow did VERDE BIO HOLDINGS, INC. generate in fiscal 2023?
Cash from operations of $872.2K minus capital expenditures of $7.0K left free cash flow of -$879.2K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.